An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...
An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a ...
FDA’s PDUFA goal date is November 1, 2026; If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease; CAMBRIDGE, Mass., Ju ...
TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell ...
In this pooled analysis of randomized crossover trials, chronic mild sleep restriction was associated with modest increases ...
Scientists are using AI and physics-based simulations together to design new peptides that will kill previously ...
For years, Snopes readers have asked whether "grounding" or "earthing" bed sheets actually work. The products contain ...
After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo treatment to a massive survival benefit versus late-day infusion in non-small cell ...
Objective: This study aimed to evaluate through a pilot unblinded randomized controlled trial the efficacy and acceptability of a Web-based psychoeducational program for informal caregivers of persons ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results